Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACC)

20 filings reported holding OACC - Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share as of Q4 2024.
Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACC) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 8.99M shares of 19.6M outstanding shares and own 45.87% of the company stock.
Largest 10 shareholders include AQR Arbitrage LLC (1.98M shares), TORONTO DOMINION BANK (1.44M shares), Boussard & Gavaudan Investment Management LLP (750K shares), Decagon Asset Management LLP (710K shares), Shaolin Capital Management LLC (550K shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (450K shares), HIGHBRIDGE CAPITAL MANAGEMENT LLC (450K shares), TWO SIGMA INVESTMENTS, LP (438K shares), GRITSTONE ASSET MANAGEMENT LLC (400K shares), and ExodusPoint Capital Management, LP (300K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.